|
Originally published In Press as doi:10.1074/jbc.M112248200 on March 21, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20783-20793, June 7, 2002
A Novel, Extraneuronal Role for Cyclin-dependent
Protein Kinase 5 (CDK5)
MODULATION OF cAMP-INDUCED APOPTOSIS IN RAT LEUKEMIA CELLS*
Tone
Sandal,
Camilla
Stapnes,
Hans
Kleivdal,
Lars
Hedin, and
Stein Ove
Døskeland
From the Department of Anatomy and Cell Biology, University of
Bergen, Bergen, 5009 Norway
A number of cyclin-dependent protein
kinase (CDK) inhibitors were tested for the ability to protect IPC-81
rat leukemic cells against cAMP-induced apoptosis. A near perfect
proportionality was observed between inhibitor potency to protect
against cAMP-induced apoptosis and to antagonize CDK5, and to a
lesser extent, CDK2 and CDK1. Enforced expression of dominant negative
CDK5 (but not CDK1-dn or CDK2-dn) protected against death, indicating
that CDK5 activity was necessary for cAMP-induced apoptosis. The CDK
inhibitors failed to protect the cells against daunorubicine-,
staurosporine-, or okadaic acid-induced apoptosis. The inhibition of
CDK5 prevented the cleavage of pro-caspase-3 in cAMP-treated cells. The
cells could be saved closer to the moment of their onset of
death by inhibitors of caspases than by inhibitors of CDK5. This
suggested that the action of CDK5 was upstream of caspase activation.
The cAMP treatment resulted in a moderate increase of the level of CDK5
mRNA and protein in IPC-81 wild-type cells. Such cAMP induction of
CDK5 was not observed in cells expressing the inducible cAMP early
repressor. The cAMP-induced increase of CDK5 contributed to apoptosis
since cells overexpressing CDK5-wt were more sensitive for
cAMP-induced death. These results demonstrate the first example of a
proapoptotic CDK action upstream of caspase activation and of an
extra-neuronal effect of CDK5.
*
This work was supported by grants from the Norwegian
Cancer Society (to T. S., S. D., and L. H.), from the Novo Nordic
Insulin Foundation (to S. D.), and from Grethe Harbitz legate (to
L. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 47-55586375;
Fax: 47-55586360; E-mail: stein.doskeland@iac.uib.no.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Liu, B. Tian, M. Gearing, S. Hunter, K. Ye, and Z. Mao
Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
PNAS,
May 27, 2008;
105(21):
7570 - 7575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, H.-S. Kim, S.-J. Lee, and K.-T. Kim
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death
J. Cell Sci.,
July 1, 2007;
120(13):
2259 - 2271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lin, M.-C. Chen, C.-Y. Chiu, Y.-M. Song, and S.-Y. Lin
Cdk5 Regulates STAT3 Activation and Cell Proliferation in Medullary Thyroid Carcinoma Cells
J. Biol. Chem.,
February 2, 2007;
282(5):
2776 - 2784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, G. David, K.-W. Hung, R. A. DePinho, A. K. Y. Fu, and N. Y. Ip
Cdk5/p35 Phosphorylates mSds3 and Regulates mSds3-mediated Repression of Transcription
J. Biol. Chem.,
December 24, 2004;
279(52):
54438 - 54444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Chen, Q. Wang, X. Wang, and G. P. Studzinski
Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell Differentiation
Cancer Res.,
August 1, 2004;
64(15):
5425 - 5433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kwon, K. L. Pappan, C. A. Marshall, J. E. Schaffer, and M. L. McDaniel
cAMP Dose-dependently Prevents Palmitate-induced Apoptosis by Both Protein Kinase A- and cAMP-Guanine Nucleotide Exchange Factor-dependent Pathways in {beta}-Cells
J. Biol. Chem.,
March 5, 2004;
279(10):
8938 - 8945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Christensen, F. Selheim, J. de Rooij, S. Dremier, F. Schwede, K. K. Dao, A. Martinez, C. Maenhaut, J. L. Bos, H.-G. Genieser, et al.
cAMP Analog Mapping of Epac1 and cAMP Kinase: DISCRIMINATING ANALOGS DEMONSTRATE THAT Epac AND cAMP KINASE ACT SYNERGISTICALLY TO PROMOTE PC-12 CELL NEURITE EXTENSION
J. Biol. Chem.,
September 12, 2003;
278(37):
35394 - 35402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sandal, L. Aumo, L. Hedin, B. T. Gjertsen, and S. O. Doskeland
Irod/Ian5: An Inhibitor of {gamma}-Radiation- and Okadaic Acid-induced Apoptosis
Mol. Biol. Cell,
August 1, 2003;
14(8):
3292 - 3304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Affaitati, L. Cardone, T. de Cristofaro, A. Carlucci, M. D. Ginsberg, S. Varrone, M. E. Gottesman, E. V. Avvedimento, and A. Feliciello
Essential Role of A-kinase Anchor Protein 121 for cAMP Signaling to Mitochondria
J. Biol. Chem.,
January 31, 2003;
278(6):
4286 - 4294.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|